Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a ...
GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...
Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...
Wave Life Sciences shares jumped in premarket trading Monday after it said it received encouraging preliminary trial data for its investigational weight loss drug WVE-007. Shares advanced nearly 78% ...
Weight-loss jab users face muscle loss comparable to “10 years of ageing” if they don’t strength train, researchers have ...
An investigational GLP-1 pill from Structure Therapeutics led to substantial weight loss, but patients also had high rates of ...
Changing consumer habits, in some cases driven by weight loss medications, inflation, and digital convenience, are reshaping ...
Serena Williams, the 23-time Grand Slam tennis champion, has taken the first step toward a potential comeback by reentering ...